U.S. Sens. Debbie Stabenow (D-MI) and Gary Peters (D-MI) penned a letter to the Dept. of Health and Human Services, urging the agency to demand that manufacturers lower the price of the opioid overdose reversal drug, naloxone.
The lawmakers wrote that the price of naloxone has climbed dramatically since it was first approved by the FDA decades ago – a two-pack of the drug’s nasal spray formulation, Narcan, costs $150, according to the senators.
Get the full story at our sister site, Drug Delivery Business News.
The post Senators urge HHS to seek lower price for naloxone appeared first on MassDevice.
from MassDevice https://ift.tt/2qJ3pYc
Cap comentari:
Publica un comentari a l'entrada